Transfer of experimental allergic encephalomyelitis to bone marrow chimeras. Endothelial cells are not a restricting element.
The adoptive transfer of clinical and histopathologic signs of experimental allergic encephalomyelitis (EAE) requires MHC compatibility between cell donor and cell recipient. The results of adoptive transfer studies using F1 to parent bone marrow chimeras as recipients of parental-derived BP-sensitive spleen cells indicate that this restriction is not expressed at the level of the endothelial cell but is confined to the cells of bone marrow derivation. Furthermore, these results indicate that the development of EAE is not dependent on the activity of MHC-restricted cytotoxic cells.
Hinrichs
D J
DJ
Veterans Administration Medical Center, Portland, Oregon 97207.
Wegmann
K W
KW
Dietsch
G N
GN
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology*; D004727:Endothelium / Q000276:immunology*; D007116:Immunization, Passive; D008285:Major Histocompatibility Complex; D011828:Radiation Chimera; D051381:Rats; D011919:Rats, Inbred Strains